Ferrer-Benito Sara, Ricard Andrés María Pilar, Murúzabal María José, Nieto Jorge M, González Fernando A, Ortega-Montero Belén, Villegas Ana, Benavente Celina, Ropero Paloma
Servicio de Hematología, Hospital Clínico San Carlos, 28040 Madrid, Spain.
Grupo de Investigación en Hematología, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos, 28040 Madrid, Spain.
Int J Mol Sci. 2025 Sep 9;26(18):8783. doi: 10.3390/ijms26188783.
Alpha-thalassemia is most often caused by large deletions within the α-globin gene cluster which reduce or abolish α-globin chain synthesis. Several common deletions are well described, but atypical structural variants remain underdiagnosed. In this study, we report three novel large heterozygous deletions of the α-globin cluster. The variants were identified in unrelated patients who presented with persistent microcytosis and hypochromia in the absence of iron deficiency or structural hemoglobin variants. A stepwise molecular diagnostic approach was applied. It combined commercial deletion screening assays, Sanger sequencing, Multiplex Ligation-dependent Probe Amplification (MLPA), and targeted Next-Generation Sequencing (NGS) with the Devyser Thalassemia panel. MLPA detected three deletions ranging from ~17 kb to ~360 kb. All involved the critical HS-40 regulatory region and both HBA1 and HBA2 structural genes, consistent with α-thalassemia alleles. Next-Generation Sequencing confirmed the extent of each deletion and refined their genomic boundaries. Comparative genomic mapping showed that these deletions are distinct from classical variants such as --SEA or --MED, indicating novel structural configurations. Clinically, all patients displayed a carrier phenotype, with normal HbF levels (<1%) and normal or slightly reduced HbA2 values. This study broadens the mutational spectrum of α-thalassemia and demonstrates the diagnostic value of combining MLPA and NGS in patients with unexplained microcytosis. By enabling accurate distinction from iron-deficiency anemia and other microcytic disorders, these findings have direct translational implications for improving diagnostic precision and genetic counseling in clinical practice.
α地中海贫血最常见的病因是α珠蛋白基因簇内的大片段缺失,这些缺失会减少或消除α珠蛋白链的合成。几种常见的缺失已得到充分描述,但非典型结构变异仍未得到充分诊断。在本研究中,我们报告了三例新的α珠蛋白簇大片段杂合缺失。这些变异在无关患者中被鉴定出来,这些患者表现为持续性小细胞性贫血和低色素血症,且不存在缺铁或结构性血红蛋白变异。我们采用了逐步分子诊断方法。该方法将商业缺失筛查检测、桑格测序、多重连接依赖探针扩增(MLPA)以及使用Devyser地中海贫血检测板的靶向新一代测序(NGS)相结合。MLPA检测到三个大小在约17 kb至约360 kb之间的缺失。所有缺失均涉及关键的HS-40调控区域以及HBA1和HBA2两个结构基因,与α地中海贫血等位基因一致。新一代测序确认了每个缺失的范围并细化了其基因组边界。比较基因组图谱显示,这些缺失与--SEA或--MED等经典变异不同,表明存在新的结构构型。临床上,所有患者均表现为携带者表型,HbF水平正常(<1%),HbA2值正常或略有降低。本研究拓宽了α地中海贫血的突变谱,并证明了在不明原因小细胞性贫血患者中联合使用MLPA和NGS的诊断价值。通过能够准确区分缺铁性贫血和其他小细胞性疾病,这些发现对提高临床实践中的诊断准确性和遗传咨询具有直接的转化意义。